《大行報告》中金再次覆蓋百濟神州(06160.HK)予「跑贏行業」評級 目標價282元
中金再次覆蓋百濟神州(06160.HK),予「跑贏行業」評級,目標價282元,指該公司建立了高效的研發平臺,並在全球範圍內建設了自有臨牀開發體系,隨着核心產品在國內外上市,公司逐步搭建了國內外的銷售體系,並取得了階段性成果,也成爲Amgen、諾華等跨國藥企在華開發銷售的重要合作夥伴。
中金指,百濟神州多層次產品管線全球佈局,核心品種進入收成期,預計其2021、2022和2023年每股虧損分別爲6.96元、5.44元、1.7元人民幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.